Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc > Down the toilet since Danter's departure

<< Previous

Bullboard Posts

Next >>

Post by XRRH2008on Nov 07, 2017 3:34pm

142 Views

Post# 26920493

Down the toilet since Danter's departure

Since bringing Allison on as President in the summer of 2016 the stock has been going down, down, down. Then with her complete lack of capital markets knowledge she does the stupid share consolidation. Look at the stock now. Trading at $0.104 pre consolidation pricing. WTF!?!

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023